HUM vs ORKA · P/E 39, rev $129.66B vs $4.27B cap
Humana Inc (HUM) versus Oruka Therapeutics, Inc. (ORKA) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Oruka Therapeutics, Inc. (ORKA) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported ORKA revenue for 2024-06-30 was $0. Net income was -$22.2M. ORKA currently screens at market cap $4.27B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. ORKA currently screens at market cap $4.27B.
Not investment advice. Open the HUM and ORKA stock pages for the full models.
Not investment advice.